EML4 and non-small cell lung carcinoma: Inversion of the short arm of chromosome 2 leads to the joining of exons 1 to 13 of EML4 and exons 20 to 29 of ALK, resulting in the EML4–ALK chimeric protein, which is known to occur in approximately 4–7% of NSCLC (28, 29).